VIA

Virtus Investment Advisers Portfolio holdings

AUM $368M
1-Year Est. Return 26.25%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+26.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$368M
AUM Growth
+$18.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
553
New
Increased
Reduced
Closed

Top Buys

1
+$2.17M
2
+$2.09M
3
+$2.03M
4
AMAT icon
Applied Materials
AMAT
+$2.01M
5
LVS icon
Las Vegas Sands
LVS
+$2.01M

Top Sells

1
+$2.5M
2
+$2.43M
3
+$2.05M
4
MS icon
Morgan Stanley
MS
+$2.04M
5
ATO icon
Atmos Energy
ATO
+$2.02M

Sector Composition

1 Healthcare 26.73%
2 Financials 22.73%
3 Technology 18.16%
4 Industrials 8.89%
5 Consumer Discretionary 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGNX icon
276
Regenxbio
RGNX
$468M
$276K 0.08%
19,181
+8,026
GPCR icon
277
Structure Therapeutics
GPCR
$4.45B
$276K 0.08%
3,967
-1,154
PCVX icon
278
Vaxcyte
PCVX
$8.92B
$276K 0.08%
5,979
+2,677
RCKT icon
279
Rocket Pharmaceuticals
RCKT
$540M
$275K 0.07%
78,474
+41,410
ZYME icon
280
Zymeworks
ZYME
$1.73B
$275K 0.07%
10,441
+1,755
ERAS icon
281
Erasca
ERAS
$4.49B
$275K 0.07%
73,896
-475
LQDA icon
282
Liquidia Corp
LQDA
$2.66B
$275K 0.07%
7,969
+95
JBIO
283
Jade Biosciences
JBIO
$692M
$274K 0.07%
+17,759
WVE icon
284
Wave Life Sciences
WVE
$2.57B
$273K 0.07%
16,064
+260
CMPS
285
Compass Pathways
CMPS
$804M
$272K 0.07%
39,471
+14,297
ABUS icon
286
Arbutus Biopharma
ABUS
$898M
$272K 0.07%
56,483
+24,699
XENE icon
287
Xenon Pharmaceuticals
XENE
$3.32B
$271K 0.07%
6,037
+2,568
VERA icon
288
Vera Therapeutics
VERA
$2.9B
$271K 0.07%
5,342
+290
CTMX icon
289
CytomX Therapeutics
CTMX
$918M
$270K 0.07%
+63,491
LXEO icon
290
Lexeo Therapeutics
LXEO
$523M
$270K 0.07%
+27,230
IDYA icon
291
IDEAYA Biosciences
IDYA
$2.95B
$270K 0.07%
7,819
+2,712
DYN icon
292
Dyne Therapeutics
DYN
$2.63B
$270K 0.07%
13,806
+5,937
CYTK icon
293
Cytokinetics
CYTK
$7.52B
$270K 0.07%
4,247
+819
CGON icon
294
CG Oncology
CGON
$4.83B
$270K 0.07%
6,497
+2,203
PROK icon
295
ProKidney
PROK
$326M
$270K 0.07%
+120,376
BEAM icon
296
Beam Therapeutics
BEAM
$2.9B
$270K 0.07%
9,724
+3,200
ANNX icon
297
Annexon
ANNX
$821M
$269K 0.07%
53,527
+11,540
RVMD icon
298
Revolution Medicines
RVMD
$19.7B
$269K 0.07%
3,371
+603
ORKA
299
Oruka Therapeutics
ORKA
$1.62B
$267K 0.07%
+8,814
RAPP
300
Rapport Therapeutics
RAPP
$1.35B
$267K 0.07%
8,789
-1,425
10 11
12
13 14